ORMP:NASDAQ
Oramed Pharmaceuticals, Inc.
$4.76
arrow_downward
-0.42%(-0.020) 1D
$4.76
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 10, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORMP...
Open
$4.74
High
$4.85
Low
$4.66
Mkt. cap
198.00M
Avg. vol.
216.73K
Volume
0.00
P/E ratio
1.15
52-wk high
$5.47
52-wk low
$2.09
EPS
$4.13
Beta
1.20
Shares outstanding
41.60M
No. of employees
13
Open
$4.74
High
$4.85
Low
$4.66
Mkt. cap
198.00M
Avg. vol.
216.73K
Volume
0.00
P/E ratio
1.15
52-wk high
$5.47
52-wk low
$2.09
EPS
$4.13
Beta
1.20
Shares outstanding
41.60M
No. of employees
13
News stories
From web sources and news partners
https://www.dars.gov.et/
·
3 weeks ago
Oramed (ORMP) EPS and Revenue: Profit Per Share Surpasses Its Benchmark in the Latest Reading; Post-Earnings: The Stock Ends Up 4.60% on the Day - Mid-Term Outlook
https://www.dars.gov.et/
·
2 months ago
Oramed Pharmaceuticals Inc. (ORMP) Q4 2025 Earnings: Surprise EPS Beat Driven by Non‑Operating Gains Amid No Revenue - Analyst Drop Coverage
Profile
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
About Oramed Pharmaceuticals, Inc.